Clinical Trial: Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement.

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663175) titled 'Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement.' on June 11.

Brief Summary: A multicenter, retrospective, observational drug study using anonymized data from adult patients with aggressive B-cell lymphoma treated with the CARMEN regimen.

The data were collected during normal clinical practice, therefore neither diagnostic approaches nor experimental drugs/devices will be applied.

Study Start Date: Nov. 01, 2022

Study Type: OBSERVATIONAL

Condition: B-cell Lymphomas With MYC Rearrangement

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: IRCCS San Raffaele

Inform...